Evidence-based co-medication in heart failure: necessary or bystander?

Freek W A Verheugt

doi:10.1002/ejhf.46

Evidence-based co-medication in heart failure: necessary or bystander?

Eur J Heart Fail. 2014 Jan;16(1):1-3. doi: 10.1002/ejhf.46. Epub 2013 Dec 14.

Author

Freek W A Verheugt¹

Affiliation

¹ P.C. Hooftstraat 188, 1071 CH Amsterdam, The Netherlands.

PMID: 24453093
DOI: 10.1002/ejhf.46

Abstract

This article refers to 'Impact of aspirin and statins on longterm survival in patients with acute myocardial infarction complicated by heart failure: an analysis in 1746 patients' by C. Lewinter et al., published in this issue on page 95-102.

Publication types

Editorial
Comment

MeSH terms

Aspirin / therapeutic use*
Heart Failure / mortality*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Inpatients*
Male
Myocardial Infarction / drug therapy*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Aspirin